Alkem Laboratories gets SEBI’s nod to raise upto 3,500 crore via IPO

27 Oct 2015 Evaluate

Drug maker Alkem Laboratories has received approval from capital markets regulator Securities and Exchange Board of India (SEBI) to raise an estimated Rs 1,500-3,500 crore through an initial public offering (IPO). This will be one of the biggest offerings in the pharma space in a long time.

Alkem Laboratories filed the Draft Red Herring Prospectus (DRHP) with SEBI on August 6 for a public issue of its equity shares. The Securities and Exchange Board of India (SEBI) has cleared the proposed initial share sale and gave its final observations on the IPO on October 19.

It has proposed to list its shares on the NSE and BSE. The issue is being managed by Nomura Financial Advisory and Securities (India), Axis Capital, J P Morgan India and Edelweiss Financial Services.

Alkem Laboratories Share Price

5431.85 -65.55 (-1.19%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.